- Home
- PNR vs ICLR Comparison
PNR vs ICLR Comparison
Compare PNR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNR
- ICLR
- Stock Information
- Founded
- PNR 1966
- ICLR 1990
- Country
- PNR United Kingdom
- ICLR Ireland
- Employees
- PNR N/A
- ICLR N/A
- Industry
- PNR Industrial Machinery/Components
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PNR Industrials
- ICLR Health Care
- Exchange
- PNR Nasdaq
- ICLR Nasdaq
- Market Cap
- PNR 17.7B
- ICLR 17.2B
- IPO Year
- PNR N/A
- ICLR 1998
- Fundamental
- Price
- PNR $102.35
- ICLR $213.26
- Analyst Decision
- PNR Buy
- ICLR Strong Buy
- Analyst Count
- PNR 16
- ICLR 9
- Target Price
- PNR $110.00
- ICLR $286.67
- AVG Volume (30 Days)
- PNR 1.1M
- ICLR 1.0M
- Earning Date
- PNR 01-28-2025
- ICLR 02-19-2025
- Dividend Yield
- PNR 0.90%
- ICLR N/A
- EPS Growth
- PNR 29.67
- ICLR 44.49
- EPS
- PNR 4.00
- ICLR 8.99
- Revenue
- PNR $4,094,500,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- PNR $0.48
- ICLR $3.96
- Revenue Next Year
- PNR $4.12
- ICLR $2.88
- P/E Ratio
- PNR $25.61
- ICLR $23.37
- Revenue Growth
- PNR N/A
- ICLR 3.63
- 52 Week Low
- PNR $68.08
- ICLR $183.38
- 52 Week High
- PNR $110.71
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- PNR 39.67
- ICLR 49.68
- Support Level
- PNR $100.45
- ICLR $200.69
- Resistance Level
- PNR $109.86
- ICLR $211.76
- Average True Range (ATR)
- PNR 1.89
- ICLR 6.63
- MACD
- PNR -1.02
- ICLR 1.35
- Stochastic Oscillator
- PNR 20.19
- ICLR 57.42
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Pentair's business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2023.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.